BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » Apolipoprotein CIII hyperactivates insulin producing beta cells

Apolipoprotein CIII hyperactivates insulin producing beta cells

Signal transduction between the diabetogenic blood factor apolipoprotein CIII (apoCIII) and insulin-producing beta cells is now clarified. ApoCIII acts upon the calcium channels through kinases PKA and Src, involving a receptor SR-BI and an integrin beta1. The results are published in Cellular and Molecular Life Sciences on the 15th of August 2013.  

Calcium is very important for a normal function of insulin-secreting beta-cells. Calcium is transported into the and out of the cells via calcium channels. Serum factor apoCIII has been identified as a cause for increased activity of these channels, leading to higher concentration of calcium and subsequently beta-cell death. So far, the signal transduction mechanism of this action has remained unknown.

Researchers in Professor P-O Berggren’s group at Karolinska Institutet have now clarified the signal transduction pathway. A joint action of beta1 integrin and SR-BI receptors, sitting in the beta-cell membrane, is needed to convey the apoCIII stimulation to the PKA and Prs kinases. A parallel activation of these kinases inside the beta cell keeps the calcium channels open and functional for a longer time.

Discovery of this molecular pathway opens opportunities for development of novel drugs for prevention of beta-cell death and development of diabetes. The results are published in Cellular and Molecular Life Sciences on the 15th of August 2013.

Read more:

Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src. Shi Y, Yang G, Yu J, Yu L, Westenbroek R, Catterall WA, Juntti-Berggren L, Berggren PO, Yang SN. Cell Mol Life Sci. 2013 Aug 15

November 26, 2013 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications May 13, 2026
  • Framsteg för stamcellsterapi vid typ 1-diabetes
    Framsteg för stamcellsterapi vid typ 1-diabetes May 13, 2026
  • Western diet can cause permanent pancreatic damage, new study finds
    Western diet can cause permanent pancreatic damage, new study finds June 13, 2025
  • Årsstämma 26 juni 2025
    Årsstämma 26 juni 2025 June 10, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved